Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Impdh2tm1Bmi mutation
(0 available);
any
Impdh2 mutation
(40 available)
|
|
|
mortality/aging
|
• no homozygotes born
• deficient numbers of homozygotes at E3.5 (blastocysts)
• very few if any actually implant
|
Allelic Composition |
Impdh2tm1Bmi/Impdh2+
|
|
Genetic Background |
involves: 129P2/OlaHsd * C57BL/6 |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Impdh2tm1Bmi mutation
(0 available);
any
Impdh2 mutation
(40 available)
|
|
|
immune system
|
• proliferative response to PMA + ionomycin moderately reduced at 72 hours
|
hematopoietic system
|
• proliferative response to PMA + ionomycin moderately reduced at 72 hours
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hprt1b-m3 mutation
(4 available);
any
Hprt1 mutation
(1274 available)
Impdh2tm1Bmi mutation
(0 available);
any
Impdh2 mutation
(40 available)
|
|
|
immune system
|
• inhibited of proliferation due to anti-CD3+anti-CD28
• approximately 30% reduction of intracellular GTP when stimulated by anti-CD3 + anti-CD28
• T cells more sensitive than B cells to guanine synthesis
• greater sensitivity to MPA inhibitition of IMPDH
|
|
• a 20-30% reduction of T cell cytolytic activity
|
hematopoietic system
|
• inhibited of proliferation due to anti-CD3+anti-CD28
• approximately 30% reduction of intracellular GTP when stimulated by anti-CD3 + anti-CD28
• T cells more sensitive than B cells to guanine synthesis
• greater sensitivity to MPA inhibitition of IMPDH
|
|
• a 20-30% reduction of T cell cytolytic activity
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Impdh1tm1Bmi mutation
(0 available);
any
Impdh1 mutation
(23 available)
Impdh2tm1Bmi mutation
(0 available);
any
Impdh2 mutation
(40 available)
|
|
|
hematopoietic system
|
• decreased lymphocyte proliferation in response to anti-CD3 together with anti-Cd28
|
|
• impairment of splenocyte proliferation also seen in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|
|
• deficient T cell cytolytic effects
|
immune system
|
• decreased lymphocyte proliferation in response to anti-CD3 together with anti-Cd28
|
|
• impairment of splenocyte proliferation also seen in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|
|
• deficient T cell cytolytic effects
|
cellular
|
• decreased lymphocyte proliferation in response to anti-CD3 together with anti-Cd28
|
|
• impairment of splenocyte proliferation also seen in response to concanavalin A, lipopolysaccharide, or to PMA + ionomycin
|